Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.46 |
| ▸ | PPARG | P37231 | 8/20 | 0.39 |
| ▸ | PPARA | Q07869 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAT2A | P31153 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21132070 | 1.00 | KIF11 (0.46) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21131611 | 0.94 | KIF11 (0.40) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21132061 | 0.91 | KIF11 (0.52) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21132055 | 0.88 | KDM4E (0.43) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21132054 | 0.88 | KDM4E (0.43) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21131612 | 0.86 | KCNH2 (0.38) | KIF11PPARGPPARA | |
| SCHEMBL21131778 | 0.85 | KIF11 (0.46) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21131815 | 0.85 | KDM4E (0.43) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21131814 | 0.85 | KDM4E (0.43) | KIF11PPARGPPARAKDM4EATM | |
| SCHEMBL21131810 | 0.84 | KIF11 (0.38) | KIF11KDM4EATML3MBTL1JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380849-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2022-07-05 | — | — | US | disclosed |
| US-20190198778-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11380849-B2 | Organic molecules for use in optoelectronic devices | OR10J3, NOX3, ORC3 | KIF11 3608/4885PPARG 4056/4885PPARA 4192/4885 |
| US-20190198778-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | ORC3, OR10J3, NOX3 | KIF11 3904/4885PPARG 4016/4885PPARA 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.